Founded in 2010, the biotech company Inbiomotion is specialized in the development of markers for the prediction of bone metastases from the analysis of the primary tumor.
Ysios capital, a venture capital firm focused on biomedicine, heads the funding round, which also involves the Fundació Vila Casas and JVRisk Technologies. This operation, the ninth since the start up of Ysios, is also the first made by this company in a spin-off from a public, basic research centre.
The increase in share capital is aimed at promoting the development of diagnostic tools for metastasis based on technology that the company licensed from IRB Barcelona and ICREA.
In the framework of the XVI National Call for Scientific and Technical Research Funding 2011, in the Life Sciences Section.
"La Festa de la Ciència i la Tecnologia" take place this weekend, June 16-17, in Barcelona's Parc de la Ciutadella
Different kinds of tumors start to develop as a result of specific combinations of errors in the processes that safeguard cell integrity.
The Tomato Genome Consortium has sequenced and assembled the genomic DNA of this fruit species, specifically of a domesticated variety, Heinz 1706. Scientists from several European centres, including Modesto Orozco, David Torrents and Xavier Pastor, researchers from the joint programme between the the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB Barcelona) have joined forces to obtain the sequence of this fruit belonging to the family Solanaceae. The sequence, as well as the results of its analysis, has just been published in the journal...
IRB Barcelona and the BBVA Foundation bring together international leaders in Barcelona to address the repair of DNA damage.
Fifty-five leading life scientists from Europe and around the world were recognized today by EMBO for their excellence in research
This family comprises a cluster of six genes that may be altered in neurological conditions, such as Parkinson’s and Charcot-Marie-Tooth disease
Work by IRB Barcelona researchers will further the study of neurodegenerative diseases such as Lafora progressive myoclonic epilepsy
On May 3-4, the European science policy lobby group the Initiative for Science in Europe (ISE), with the support of the Institute for Research in Biomedicine (IRB Barcelona), the Ramon Areces Foundation and the Government of Catalonia, will hold its annual conference at the Institute for Catalan Studies in Barcelona.
Under the title of “Strengthening the European Research Area: What Does Science Need to Flourish?”, the ISE will bring together key players in europe to discuss aspects such as how to involve of scientists in the governance of the European Research Area (ERA) and how to organise cross-border research collaboration.